Conducted by Atalan and Harvard, the study highlights how solely relying on survey data misses key trends in physician behaviors.

The soon-to-be U.S. owner of TikTok, which has 170 million users, 7 million of which use the app for business, was not ...

FDA rolls out more warning letters; Novo’s new obesity drug shows success; Former CDC officials go after RFK Jr.

The FDA published about 40 warning letters on its website about pharma ads that the agency deemed “misleading.” ...

The medical apparel brand also launched the final installment of its successful Where Do You Wear Your Figs? campaign two days after the unexpected fashion moment honoring healthcare professionals.

Pharma marketers see AI as shifting beyond being just a productivity tool to one that can foster trust among consumers.

Public health experts have warned of the perils of falls for older people for decades. In 2023, the most recent year of data from the Centers for Disease Control and Prevention, more than 41,000 ...

A key federal vaccine advisory panel whose members were recently replaced by Health and Human Services Secretary Robert F. Kennedy Jr. is expected to vote to recommend delaying until age 4 the ...

Many patients are using large language models, or LLMs, like OpenAI’s ChatGPT, Anthropic’s Claude, and Google’s Gemini, to interpret their medical records.

FDA’s warning letter to AstraZeneca; FDA Commissioner critiques Hims & Hers’ Super Bowl ad; Nine burning questions about pharma ads.

Tremfya is back on top, securing the No. 1 spot for TV pharma brand ad impressions in August. The Johnson and Johnson brand achieved an impressions SOV of 5.18%, securing 2.9 billion impressions with ...

A letter signed by CBER Director Vinay Prasad informed AstraZeneca that the FDA determined that its minute-long TV ad promoting FluMist is “false or misleading.” ...